fda glp-1 compounding crackdown news october 2025 to Restrict Ingredients Used in Mass-Marketed Compounded GLP-1s, Crack Down on Misleading Ads FDA steps up crackdown on

Many new users under-eat without realizing it, which sends fatigue into overdrive

Avoid sellers that skip a real clinical review or sell from unverified sources

This will force other GLP-1 originators, such as tirzepatide and mazdutide, to reevaluate their pricing and market entry strategies and compel pipeline developers to recalibrate their China launch plans accordingly

Despite adjusting for these factors, Native Americans had 2.8 times increased odds of early 30-day mortality and 2.3 times greater risk of long-term transplant-free mortality following the TIPS procedure

Participants will be assigned to either the experimental group taking the CT-996 drug or the placebo comparator group